| Mary Margaret Stuvland, | |
|
1406 6th Ave N, Saint Cloud, MN 56303 | |
| (320) 251-2700 | |
| Not Available |
| Full Name | Mary Margaret Stuvland |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 19 Years |
| Location | 1406 6th Ave N, Saint Cloud, Minnesota |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033348222 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Secondary |
| 235Z00000X | Speech-language Pathologist | 7977 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Cloud Hospital | 4880594779 | 188 |
News Archive
K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced a major expansion of the company's U.S. biologics offering with the launch of its VESUVIUS™ Osteobiologic Systems and new additions to its VIKOS® Allograft Systems. K2M is working with LifeNet Health®, a leading allograft bio-implant and regenerative medicine company, to bring to market quality implants to enhance bone regeneration and osteoconductivity.
Physicians found that signs, symptoms and identifiable risk factors are absent in more than half of the mothers of infants with congenital toxoplasmosis in a national study of children with this disease.
Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have identified a biological process that may help physicians predict when someone with heart disease is likely to have a heart attack in the near future.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
Broadcast for the first time to a UK audience, visitors to the Dana Centre will not only watch live surgery, but be able to direct questions to the surgical team in the USA whilst the operation takes place.
› Verified 5 days ago
| Provider Name | Centracare Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043212665 PECOS PAC ID: 2466363395 Enrollment ID: O20031105000293 |
News Archive
K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced a major expansion of the company's U.S. biologics offering with the launch of its VESUVIUS™ Osteobiologic Systems and new additions to its VIKOS® Allograft Systems. K2M is working with LifeNet Health®, a leading allograft bio-implant and regenerative medicine company, to bring to market quality implants to enhance bone regeneration and osteoconductivity.
Physicians found that signs, symptoms and identifiable risk factors are absent in more than half of the mothers of infants with congenital toxoplasmosis in a national study of children with this disease.
Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have identified a biological process that may help physicians predict when someone with heart disease is likely to have a heart attack in the near future.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
Broadcast for the first time to a UK audience, visitors to the Dana Centre will not only watch live surgery, but be able to direct questions to the surgical team in the USA whilst the operation takes place.
› Verified 5 days ago
| Provider Name | St Cloud Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043269798 PECOS PAC ID: 4880594779 Enrollment ID: O20110221000134 |
News Archive
K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced a major expansion of the company's U.S. biologics offering with the launch of its VESUVIUS™ Osteobiologic Systems and new additions to its VIKOS® Allograft Systems. K2M is working with LifeNet Health®, a leading allograft bio-implant and regenerative medicine company, to bring to market quality implants to enhance bone regeneration and osteoconductivity.
Physicians found that signs, symptoms and identifiable risk factors are absent in more than half of the mothers of infants with congenital toxoplasmosis in a national study of children with this disease.
Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have identified a biological process that may help physicians predict when someone with heart disease is likely to have a heart attack in the near future.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
Broadcast for the first time to a UK audience, visitors to the Dana Centre will not only watch live surgery, but be able to direct questions to the surgical team in the USA whilst the operation takes place.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Margaret Stuvland, 1406 6th Ave N, Saint Cloud, MN 56303-1901 Ph: (320) 251-2700 | Mary Margaret Stuvland, 1406 6th Ave N, Saint Cloud, MN 56303 Ph: (320) 251-2700 |
News Archive
K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced a major expansion of the company's U.S. biologics offering with the launch of its VESUVIUS™ Osteobiologic Systems and new additions to its VIKOS® Allograft Systems. K2M is working with LifeNet Health®, a leading allograft bio-implant and regenerative medicine company, to bring to market quality implants to enhance bone regeneration and osteoconductivity.
Physicians found that signs, symptoms and identifiable risk factors are absent in more than half of the mothers of infants with congenital toxoplasmosis in a national study of children with this disease.
Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have identified a biological process that may help physicians predict when someone with heart disease is likely to have a heart attack in the near future.
Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.
Broadcast for the first time to a UK audience, visitors to the Dana Centre will not only watch live surgery, but be able to direct questions to the surgical team in the USA whilst the operation takes place.
› Verified 5 days ago
Erin Titus, MS, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2848 2nd St S Ste 155, Saint Cloud, MN 56301 Phone: 320-200-4473 | |
Brenna K Voss, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2835 W Saint Germain St, Saint Cloud, MN 56301 Phone: 320-259-4151 | |
Julia Barrette, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2835 W Saint Germain St Ste 300, Saint Cloud, MN 56301 Phone: 320-259-4151 Fax: 320-259-5707 | |
Shawn Merritt, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4801 Veterans Dr, Building 116, Saint Cloud, MN 56303 Phone: 320-255-6480 | |
Kristine A Hassebrock, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1406 6th Ave N, Saint Cloud, MN 56303 Phone: 320-251-2700 Fax: 320-656-7115 | |
Kathy Kuhl, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1406 6th Ave N, Saint Cloud, MN 56303 Phone: 320-251-2700 |